My next point was around complexity, and that really touches on the fact that it is a very technical piece of legislation. If we look, for example, as early as the second line of the explanatory note, the select committee will need to turn its mind to the differences and relative merits of "tobacco smoking products, herbal smoking products, smokeless tobacco products, and vaping products". To allow them the time that they need to gain expert advice on the differences between those from a health perspective, and I suppose from a justice perspective as well, is very important. I don't think that we should tie the hands of the select committee any more than would be the case normally in terms of a reporting period in relation to their very important duty to consider those details. 